Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
- Status
- COMPLETED
- Phase
- PHASE4
Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE2
The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease
- Status
- COMPLETED
- Phase
- NA
GLORIA-AF Registry Program - Second and Third Phases
- Status
- COMPLETED
- Phase
- N/A
DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
- Status
- COMPLETED
- Phase
- PHASE2
Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids
- Status
- WITHDRAWN
- Phase
- PHASE2
Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone
- Status
- WITHDRAWN
- Phase
- PHASE2
Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China
- Status
- COMPLETED
- Phase
- PHASE4
Dabigatran Etexilate in Patients With Mechanical Heart Valves
- Status
- TERMINATED
- Phase
- PHASE2
Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.
- Status
- COMPLETED
- Phase
- PHASE1
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control
- Status
- COMPLETED
- Phase
- PHASE4
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
GLORIA-AF Registry Program (Phase I)
- Status
- COMPLETED
- Phase
- N/A